Home › Funds › Tower Research Capital LLC (TRC) › BTI
Tower Research Capital LLC (TRC) position in BTI
BRITISH AMERN TOB PLC · Health Care
Tower Research Capital LLC (TRC) reported holding 230,620 shares of BTI (BRITISH AMERN TOB PLC) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 0.35% of its reported portfolio and ranking #45 among its reported holdings. Tower Research Capital LLC (TRC) has disclosed BTI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tower Research Capital LLC (TRC)'s BTI position evolved
Tower Research Capital LLC (TRC) first disclosed a stake in BTI in Q3 2023 at 10,432 shares (US$328K). The position peaked in Q2 2026 at 230,620 shares, worth US$14.2M. Across 12 filings, Tower Research Capital LLC (TRC) increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 230,620 shares valued at US$14.2M — an increase of 200,787 shares quarter over quarter.. Notable position changes include a 389% increase in Q4 2023 (shares rose 4% over the following quarter), a 562% increase in Q3 2024 (shares were roughly flat over the following quarter), a 673% increase in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 10.43K | $327.67K | New |
| Q4 2023 | 51.05K | $1.50M | Add |
| Q1 2024 | 29.00K | $884.53K | Reduce |
| Q2 2024 | 5.48K | $169.44K | Reduce |
| Q3 2024 | 36.26K | $1.33M | Add |
| Q4 2024 | 95.01K | $3.45M | Add |
| Q1 2025 | 125.66K | $5.18M | Add |
| Q2 2025 | 248.22K | $11.75M | Add |
| Q3 2025 | 221.40K | $11.75M | Reduce |
| Q4 2025 | 69.51K | $3.94M | Reduce |
| Q1 2026 | 29.83K | $1.74M | Reduce |
| Q2 2026 | 230.62K | $14.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BTI and 13F data
BTI (BRITISH AMERN TOB PLC) is a Health Care company. 34 other funds we track also report a position in BTI — the largest reported positions include Capital International Investors (US$3.04B), GQG Partners LLC (US$1.52B), Orbis Allan Gray Ltd (US$456.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BTI
- Capital International Investors 49.13M sh · $3.04B · Q2 2026
- GQG Partners LLC 24.57M sh · $1.52B · Q2 2026
- Orbis Allan Gray Ltd 7.39M sh · $456.12M · Q2 2026
- Mondrian Investment Partners LTD 4.36M sh · $237.05M · Q3 2026
- Marshall Wace 3.27M sh · $202.01M · Q2 2026
- Newport Trust Company, LLC 2.48M sh · $153.47M · Q2 2026
- Cullen Capital Management, LLC 2.18M sh · $134.37M · Q2 2026
- Maple Rock Capital Partners Inc. 2.17M sh · $133.77M · Q2 2026
- Empyrean Capital Partners, LP 1.93M sh · $118.89M · Q2 2026
- Capital International, Inc./CA/ 1.58M sh · $97.48M · Q2 2026
More on Tower Research Capital LLC (TRC)
FAQ
How long has Tower Research Capital LLC (TRC) held BTI?
Tower Research Capital LLC (TRC) has disclosed BTI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Tower Research Capital LLC (TRC)'s current position in BTI?
As of Q2 2026, Tower Research Capital LLC (TRC) holds 230.62K shares of BTI (BRITISH AMERN TOB PLC), valued at $14.24M, representing 0.35% of its reported portfolio and ranking #45.
Has Tower Research Capital LLC (TRC) been buying or selling BTI?
In the latest 13F filing (Q2 2026), Tower Research Capital LLC (TRC) increased its position in BTI. The position peaked in Q2 2026 at 230.62K shares.
Which other funds hold BTI?
Other major institutional holders of BTI include Capital International Investors, GQG Partners LLC, Orbis Allan Gray Ltd, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.